Acute mountain sickness in travelers who consulted a pre-travel clinic

Journal of Travel Medicine

Volumn 18, Issue 5, 2011, Pages 337-343

  Croughs, Mieke ^a,b   Van Gompel, Alfons ^b   Van Den Ende, Jef ^b  

^a GGD Hart voor Brabant   (Netherlands)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE;

ADOLESCENT; ADULT; AGED; ALTITUDE DISEASE; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; COUGHING; DRUG EFFECT; DRUG INDUCED HEADACHE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; PATIENT COMPLIANCE; PREDICTION; PROPHYLAXIS; RISK FACTOR; SLEEP; TASTE DISORDER; TRAVEL; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALTITUDE SICKNESS; BELGIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOUNTAINEERING; NETHERLANDS; ODDS RATIO; PATIENT COMPLIANCE; PROGNOSIS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TRAVEL; YOUNG ADULT;

EID: 80052459630     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2011.00537.x     Document Type: Article

References (31)

1. Subedi D, Marahatta R, Sharma S, et al., Trekkers' awareness of acute mountain sickness and acetazolamide. Wilderness Environ Med 2008; 19: 321-322.
2. Vardy J, Vardy J, Judge K., Can knowledge protect against acute mountain sickness? J Public Health (Oxf) 2005; 27: 366-370.
3. Merritt AL, Camerlengo A, Meyer C, Mull JD., Mountain sickness knowledge among foreign travelers in Cuzco, Peru. Wilderness Environ Med 2007; 18: 26-29.
4. Gaillard S, Dellasanta P, Loutan L, Kayser B., Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up. High Alt Med Biol 2004; 5: 410-419.
5. Paz A, Steinfeld I, Potasman I., Are we doing our best to educate travelers about the risks of acute mountain sickness? An on-site prospective study in the Himalayas. J Travel Med 2007; 14: 168-172.
6. Townend M., Sources and appropriateness of medical advice for trekkers. J Travel Med 1998; 5: 73-79.
7. Bartsch P, Bailey DM, Berger MM, et al., Acute mountain sickness: controversies and advances. High Alt Med Biol 2004; 5: 110-124.
8. Hackett PH, Roach RC., High-altitude illness. N Engl J Med 2001; 345: 107-114.
9. Luks AM, Swenson ER., Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness. Chest 2008; 133: 744-755.
10. Basnyat B, Murdoch DR., High-altitude illness. Lancet 2003; 361: 1967-1974.
11. Hacket PH, Roach RC., High-altitude medicine. In:, Auerbach PS, ed. Wilderness medicine. 5th Ed. Philadelphia: Mosby Elsevier, 2007: 2-36.
12. Murdoch DR., Prevention and treatment of high-altitude illness in travelers. Curr Infect Dis Rep 2004; 6: 43-49.
13. Luks AM, McIntosh SE, Grissom CK, et al., Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med 2010; 21: 146-155.
14. Mairer K, Wille M, Bucher T, Burtscher M., Prevalence of acute mountain sickness in the Eastern Alps. High Alt Med Biol 2009; 10: 239-245.
15. Wagner DR, D'Zatko K, Tatsugawa K, et al., Mt. Whitney: determinants of summit success and acute mountain sickness. Med Sci Sports Exerc 2008; 40: 1820-1827.
16. Dallimore J, Rowbotham EC., Incidence of acute mountain sickness in adolescents. Wilderness Environ Med 2009; 20: 221-224.
17. Murdoch DR., Altitude illness among tourists flying to 3740 meters elevation in the Nepal Himalayas. J Travel Med 1995; 2: 255-256.
18. Hackett PH, Rennie D, Levine HD., The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976; 2: 1149-1155.
19. Wagner DR, Fargo JD, Parker D, et al., Variables contributing to acute mountain sickness on the summit of Mt Whitney. Wilderness Environ Med 2006; 17: 221-228.
20. Beidleman BA, Fulco CS, Muza SR, et al., Effect of six days of staging on physiologic adjustments and acute mountain sickness during ascent to 4300 meters. High Alt Med Biol 2009; 10: 253-260.
21. Basnyat B, Lemaster J, Litch JA., Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas. Aviat Space Environ Med 1999; 70: 867-873.
22. Basnyat B, Subedi D, Sleggs J, et al., Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high-altitude cerebral edema at a sacred lake at 4300 m in the Nepal Himalayas. Wilderness Environ Med 2000; 11: 89-93.
23. Davies AJ, Kalson NS, Stokes S, et al., Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m). Wilderness Environ Med 2009; 20: 311-317.
24. Basnyat B, Gertsch JH, Holck PS, et al., Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. High Alt Med Biol 2006; 7: 17-27.
25. Basnyat B, Gertsch JH, Johnson EW, et al., Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol 2003; 4: 45-52.
26. van Patot MC, Leadbetter G III, Keyes LE, et al., Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt Med Biol 2008; 9: 289-293.
27. Carlsten C, Swenson ER, Ruoss S., A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m). High Alt Med Biol 2004; 5: 33-39.
28. Dumont L, Mardirosoff C, Tramer MR., Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ 2000; 321: 267-272.
29. Wright A, Brearey S, Imray C., High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high-altitude cerebral and pulmonary oedema. Expert Opin Pharmacother 2008; 9: 119-127.
30. Grissom CK, Roach RC, Sarnquist FH, Hackett PH., Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med 1992; 116: 461-465.
31. Magill AJ., Expert Opinions in Travel Medicine. Prepare woman with hypertension for travel to altitude. 2006. Available at:. (Accessed 2011 May)